Applied Genetic Technologies (AGTC) Tops Q3 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. BROS
3. ARM
4. FIS
5. EXPE
6. QCOM
7. DDOG
8. PAYC
9. CHYM
10. CPAY

Go back to Applied Genetic Technologies (AGTC) Tops Q3 EPS by 6c

Applied Genetic Technologies' (AGTC) Investigational Gene-Based Therapy for AAT Deficiency Demonstrates Durable Response at Five Years

May 5, 2016 7:31 AM EDT

Researchers from the University of Massachusetts Medical School today announced new data evaluating the efficacy of an investigational adeno-associated virus (AAV) vector gene therapy treatment for alpha-1 antitrypsin (AAT) deficiency, an inherited genetic defect that results in severe loss of lung function. The investigational gene therapy was developed by Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of gene therapies for the treatment of rare diseases. Study results were presented in a podium session at the American Society of Gene and Cell Therapy (ASGCT) 19th Annual Meeting, taking place from May... More